Literature DB >> 15813639

Guillain-Barre syndrome occurring after rabies vaccination.

Arifrasheed Siddiqui1, Rehman Izhar Usmani, Saleem Anwer, Salahuddin Afsar.   

Abstract

A variety of events are associated with the onset of Guillain-Barre syndrome, including vaccinations and vaccines. These are the swine influenza vaccine, oral poliovirus vaccine and rabies vaccine. Rabies is a uniformly fatal disease. It is preventable if World Health Organization (WHO) guidelines for post exposure treatment (PET) are followed. These include local treatment of wound, passive immunization with rabies immunoglobulins and administration of a efficacious vaccine. Cell culture vaccines are highly immunogenic with fewer side effects, but are costly. For that reason neurotissue vaccines are still widely used in Pakistan, although they are less immunogenic with higher incidence of neuroparalytic complications. We report a case of Guillain-Barre syndrome secondary to sheep brain anti-rabies vaccine in a young boy, who presented with lower limb weakness with total recovery after treatment.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15813639

Source DB:  PubMed          Journal:  J Pak Med Assoc        ISSN: 0030-9982            Impact factor:   0.781


  3 in total

1.  Guillain-Barre syndrome following oral polio vaccination.

Authors:  Salman Naeem; Asma Shabbir; Abdus Salam Khan; Samia Ahmad; Khawaja Junaid Mustafa; Ammad Fahim
Journal:  J Neurovirol       Date:  2015-12-14       Impact factor: 2.643

Review 2.  Vaccines and Guillain-Barré syndrome.

Authors:  Penina Haber; James Sejvar; Yann Mikaeloff; Frank DeStefano
Journal:  Drug Saf       Date:  2009       Impact factor: 5.228

3.  Acute paretic syndrome in juvenile White Leghorn chickens resembles late stages of acute inflammatory demyelinating polyneuropathies in humans.

Authors:  Sophie R Bader; Sonja Kothlow; Sascha Trapp; Susanne Cn Schwarz; Hans-Christian Philipp; Steffen Weigend; Ahmad R Sharifi; Rudolf Preisinger; Wolfgang Schmahl; Bernd Kaspers; Kaspar Matiasek
Journal:  J Neuroinflammation       Date:  2010-01-28       Impact factor: 8.322

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.